Wednesday , July 18 2018
Home / Conditions / Obesity / Medicare Now Pays for Intensive Obesity Counseling

Medicare Now Pays for Intensive Obesity Counseling

Dec 2, 2011

Medicare will pick up the tab for obesity screening and intensive behavioral counseling, the Centers for Medicare and Medicaid announced this week.

CMS, which first floated the obesity coverage plan last September, said it expects more than 30% of the Medicare population to qualify for the new benefit. Beneficiaries with body mass index values of 30 or more can receive weekly in-person intensive behavioral therapy visits for one month, followed by visits every two weeks for an additional five months, fully paid by Medicare with no copayment.

Additional monthly sessions will be covered for up to six months afterward if the beneficiary has lost at least 6.6 pounds (3 kg) during the first six months. The sessions should also include dietary counseling, the agency said.

Medicare patients who fail to lose the 6.6 pounds in six months may be reevaluated at the one-year mark after the initial screening. Those showing “readiness to change” and a BMI value still at 30 or more may receive another round of counseling paid by Medicare.

Outgoing CMS administrator Donald Berwick, MD, stated that, “It’s important for Medicare patients to enjoy access to appropriate screening and preventive services.”

Counseling must take place in a primary care setting such as a physician’s office. It will not be covered when provided in skilled nursing facilities, hospitals, emergency departments, outpatient surgery centers, or hospices.

A primary care setting is defined as “one in which there is provision of integrated, accessible healthcare services by clinicians who are accountable for addressing a large majority of personal healthcare needs, developing a sustained partnership with patients, and practicing in the context of family and community.”

Peter Jacobson, JD, MPH, a health policy professor at the University of Michigan in Ann Arbor, stated that the decision is important in its own right, but will be even more significant if private insurers follow suit to cover such counseling. But taking issue with the benefit’s restriction to counseling provided only in primary care settings — referrals to specialty practices or centers for counseling will not be covered by Medicare.

Jacobson said, “Primary care is necessary but not sufficient to address the obesity epidemic.” “Without community-based services and referrals, the overall policy impact may not be as robust as would a policy linking medical care with public health.”

In an ABV interview another health policy expert, Robert Field, JD, MPH, PhD, of Drexel University in Philadelphia, said, “If people are obese when they reach old age, they probably have a lifetime of bad habits that will be difficult to break.”

To qualify under the new benefit, counseling must be consistent with the “five A’s” listed in a U.S. Preventive Services Task Force recommendation, according to CMS’s decision memo:

  • Assess: Ask about/assess behavioral health risk(s) and factors affecting choice of behavior change goals/methods.
  • Advise: Give clear, specific, and personalized behavior change advice, including information about personal health harms and benefits.
  • Agree: Collaboratively select appropriate treatment goals and methods based on the patient’s interest in and willingness to change the behavior.
  • Assist: Using behavior change techniques (self-help and/or counseling), aid the patient in achieving agreed-upon goals by acquiring the skills, confidence, and social/environmental supports for behavior change, supplemented with adjunctive medical treatments when appropriate.
  • Arrange: Schedule follow-up contacts (in person or by telephone) to provide ongoing assistance/support and to adjust the treatment plan as needed, including referral to more intensive or specialized treatment.

CMS has no plans to hold a Medicare Coverage Advisory Committee meeting on this topic, which the agency often does to hear the evidence paying for a new drug or device. It is accepting additional public comments and will eventually issue a final coverage decision.